On the first question, the clinical evidence base for GLP-1 receptor agonists is substantial and well-documented across multiple independent research organizations
All three active treatments decreased GFR but not UACR
(JMIR, 2023) We don't bill insurance directly, but we offer several affordable payment options that make GLP-1 weight loss treatment accessible
What is clear is that the crackdown on compounding is a major win for the drug companies, and telemedicine services will need to play nice with them to keep their GLP-1 supply flowing
GLP-1 receptor agonists are medications (such as semaglutide, tirzepatide, and liraglutide) that mimic a natural gut hormone, helping lower blood sugar, reduce appetite, promote weight loss, and decrease inflammation. Can GLP-1 medications help with both diabetes and weight loss